Losing a pregnancy is painful. Losing more than one can leave you searching for answers and wondering whether anything can be done differently next time. If you have had two or more miscarriages, you are dealing with what doctors call recurrent pregnancy loss — and while the experience is deeply personal, the medical picture is clearer than many people expect. This article explains what recurrent pregnancy loss means, the causes doctors look for, the tests that are usually recommended, and where progesterone genuinely fits in based on current evidence.
What is recurrent pregnancy loss?
Recurrent pregnancy loss (RPL) is generally defined as the loss of two or more pregnancies. Leading bodies such as the European Society of Human Reproduction and Embryology (ESHRE) and the American Society for Reproductive Medicine (ASRM) use this two-loss definition, while some UK guidance has historically used three or more losses before starting a full evaluation. The losses do not have to be consecutive to be worth investigating.
Two points are worth holding onto. First, RPL is not rare — a meaningful minority of couples experience it, so you are far from alone. Second, and importantly, even after recurrent losses, many couples go on to have a healthy pregnancy, particularly once treatable factors have been identified and addressed.
Why does recurrent pregnancy loss happen?
There is rarely a single, simple explanation. Doctors think about several categories of cause, and sometimes more than one is present.
Chromosomal and genetic factors
Most one-off (sporadic) miscarriages happen because of a random chromosomal error in the embryo — an issue that becomes more common as a woman gets older. In recurrent loss, a smaller but important sub-group involves a parental chromosomal rearrangement, such as a balanced translocation, in one partner. The partner is usually healthy, but the way their chromosomes are arranged can raise the chance of an embryo receiving an unbalanced set.
Uterine and anatomical factors
The shape and lining of the uterus matter. A septate uterus (a band of tissue dividing the cavity) is the anatomical variation most consistently linked with pregnancy loss. Other structural factors can include submucosal fibroids that distort the cavity, intrauterine adhesions (scar tissue), and endometrial polyps. Current guidance also recognises adenomyosis as a factor worth considering.
Antiphospholipid syndrome
Antiphospholipid syndrome (APS) is an autoimmune condition in which the body makes antibodies that increase clotting tendency and interfere with the placenta. It is one of the most important treatable causes of recurrent loss, which is why testing for it is a standard part of the work-up.
Endocrine and metabolic factors
Hormonal and metabolic health influence early pregnancy. Poorly controlled thyroid disease (over- or under-active), poorly controlled diabetes, and possibly certain features linked to polycystic ovary syndrome may be associated with higher loss risk. These are often manageable once identified.
Lifestyle and other factors
Some modifiable factors — smoking, heavy alcohol use, a high body-mass index, and very high caffeine intake — may be associated with increased risk. The evidence is strongest for treating them as sensible targets rather than guaranteed causes. Emerging research is also looking at male factors, such as sperm DNA quality, though this remains an area of uncertainty.
Unexplained recurrent pregnancy loss
Here is something many people are not told clearly: even after a thorough evaluation, around half of couples receive no definite explanation. This is frustrating, but it is not the same as “no hope.” Couples with unexplained RPL often still have a good chance of a successful future pregnancy.
| Category | Examples | How it may be evaluated |
|---|---|---|
| Genetic | Parental balanced translocation; embryo chromosome errors | Analysis of pregnancy tissue; selective parental karyotyping |
| Anatomical | Septate uterus, adhesions, submucosal fibroids, adenomyosis | Pelvic ultrasound, saline sonography, hysteroscopy or MRI |
| Immune / clotting | Antiphospholipid syndrome | Blood tests for antiphospholipid antibodies, repeated to confirm |
| Endocrine | Thyroid dysfunction, poorly controlled diabetes | Thyroid function tests, blood glucose/HbA1c where relevant |
| Unexplained | No cause found after work-up | Diagnosis of exclusion; supportive early-pregnancy care |
How is recurrent pregnancy loss evaluated?
Evaluation is a structured, stepwise process, not a scattergun of tests. Your clinician will usually start with a detailed history and examination, then consider :
- Imaging of the uterus — a pelvic ultrasound, sometimes followed by saline sonography, hysteroscopy or MRI if an anatomical issue is suspected.
- Antiphospholipid antibody testing — checking for lupus anticoagulant, anticardiolipin and anti-β2-glycoprotein-I antibodies. Because a single result can be misleading, positive tests are repeated after an interval to confirm.
- Thyroid and metabolic checks — thyroid function, and blood-sugar assessment where appropriate.
- Genetic analysis — testing of pregnancy tissue after a loss (increasingly using array-based technology) can reveal whether a chromosomal error was involved, and parental karyotyping may be offered selectively.
Equally important is what usually should not be done routinely. Broad panels for inherited clotting disorders and many “immune” tests are not recommended for everyone, because they rarely change management and can cause anxiety. A good work-up focuses on tests that lead to action.
The role of progesterone : what the evidence actually says
Progesterone is a hormone produced first by the corpus luteum (the structure left after ovulation) and later by the placenta. It prepares the uterine lining for implantation and helps sustain early pregnancy. Because of this role, progesterone supplementation has long been of interest for preventing miscarriage — but the honest answer is more nuanced than “it works” or “it doesn’t.”
Two large, well-designed UK trials shaped current thinking :
- The PROMISE trial studied women with unexplained recurrent miscarriage who were not bleeding. It found that progesterone did not significantly improve live-birth rates in this group.
- The PRISM trial studied women with early-pregnancy bleeding. Overall, progesterone did not produce a statistically significant benefit for everyone. However, a planned sub-group analysis suggested a benefit for women who had both early-pregnancy bleeding and one or more previous miscarriages — with the largest effect seen in those who had experienced three or more previous losses.
On the strength of this evidence, the UK’s National Institute for Health and Care Excellence (NICE) recommends offering vaginal micronised progesterone to women who have early-pregnancy bleeding and a history of at least one previous miscarriage. The regimen studied and recommended in that guidance is a specific dose given until 16 weeks of pregnancy — but the dose, route and duration are decisions for your clinician, based on your situation, not something to start on your own.
A related option, dydrogesterone (an oral progestogen widely used in India and elsewhere), has also been studied in threatened miscarriage with some supportive findings, though the overall evidence base continues to evolve.
What this means in practice:
- Progesterone is not a universal cure for recurrent miscarriage, and it does not prevent all losses.
- The clearest benefit is in a specific group — women with early-pregnancy bleeding plus previous miscarriage(s).
- For unexplained recurrent loss without bleeding, the evidence does not support progesterone as a standard preventive treatment.
- Whether progesterone is right for you is an individual decision to make with your doctor.
Planning a future pregnancy
If you are trying again, a few things genuinely help: treating any identified cause (for example, APS or thyroid disease), optimising modifiable factors before conception, and arranging supportive early-pregnancy care so you can be seen and reassured promptly. Many specialist units offer dedicated recurrent-miscarriage support, and being cared for by a familiar team is something couples often value greatly.
When to see a specialist
Consider seeing a gynaecologist or fertility specialist after two pregnancy losses, or sooner if you have known risk factors, are older, or have other symptoms that concern you. A specialist can arrange the right evaluation, explain your individual results, and discuss whether any treatment — including progesterone — is appropriate for your circumstances.
FAQs :
Q1. What is considered recurrent pregnancy loss?
Recurrent pregnancy loss is usually defined as two or more pregnancy losses. The losses do not have to be consecutive to warrant evaluation.
Q2. How common is recurrent pregnancy loss?
It affects a meaningful minority of couples. The exact figure depends on the definition used, but it is common enough that dedicated clinics and guidelines exist specifically for it.
Q3. What tests are done for recurrent miscarriage?
Typical evaluation includes a pelvic ultrasound (and sometimes hysteroscopy or MRI), antiphospholipid antibody blood tests repeated to confirm, thyroid and metabolic checks, and — where appropriate — genetic analysis of pregnancy tissue and parental karyotyping.
Q4. Can progesterone prevent miscarriage?
Not in every case. Current evidence supports offering vaginal micronised progesterone mainly to women who have early-pregnancy bleeding together with one or more previous miscarriages. It is not proven to help unexplained recurrent loss without bleeding.
Q5. Will I be able to have a healthy pregnancy after recurrent losses?
Many couples do, especially once treatable causes are addressed. Even when no cause is found, the outlook is often reassuring, though it should be discussed individually with your doctor.
Q6. Is recurrent pregnancy loss my fault?
No. The great majority of causes are chromosomal, anatomical, immune or hormonal — none of which are caused by anything you did.
Q7. When should I see a doctor?
After two losses, or earlier if you have risk factors or concerning symptoms. A specialist can guide the evaluation and any treatment.
Conclusion
Recurrent pregnancy loss is difficult, but it is a recognised medical condition with a structured approach to evaluation and, in many cases, treatable causes. Progesterone has a real but specific role — helpful for particular situations, not a blanket solution. The most useful next step is a proper evaluation with a qualified specialist, who can interpret your results and help you plan a future pregnancy with realistic, evidence-based hope.
Medical Disclaimer
This article is for general educational purposes only and does not constitute medical advice, diagnosis or treatment. It is not a substitute for consultation with a qualified gynaecologist, obstetrician or fertility specialist. Do not start, stop or change any medication — including progesterone — without professional guidance. If you are pregnant and experiencing bleeding or pain, seek medical care promptly.